infohep news

• Hepatitis C vaccine fails to prevent chronic infection

  Liz Highleyman / 10 October 2019

  An experimental two-part vaccine was not able to prevent chronic hepatitis C virus (HCV) infection in a mid-stage study, according to a presentation at the recent IDWeek 2019 conference in Washington, DC. Prof. Andrea ...

• Treatment for people who use drugs

  People who use drugs would prefer to get hepatitis C treatment at a community pharmacy

  Keith Alcorn / 04 October 2019

  Seventy-eight per cent of people using needle and syringe programmes in community pharmacies in London who opted to test for hepatitis C would prefer to receive their hepatitis C treatment from the ...

• NAFLD

  Non-alcoholic fatty liver disease raises the risk of cancer in overweight people

  Keith Alcorn / 24 September 2019

  Obesity without non-alcoholic fatty liver disease (NAFLD) does not raise the risk of cancer, but people with NAFLD who are also obese are almost twice as likely to be diagnosed with cancer ...

• NAFLD

  Fatty liver raises the risk of death in people with HIV and hepatitis C

  Keith Alcorn / 15 September 2019

  People with HIV and hepatitis C co-infection who had fatty liver disease were twice as likely to die during a five-year follow-up period as their counterparts without fatty liver disease, ...

• When is HCV cured?

  Does hepatitis C virus remain in the body after successful treatment?

  Keith Alcorn / 11 September 2019

  Persistence of very low-level hepatitis C infection after a sustained virologic response to hepatitis C treatment is an extremely rare event and is not associated with any liver damage, Spanish ...